Litcius/Paper detail

Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine

Duo Liu, Xuehua Li, Xiang Li, Huiqi Wang, Mei Dong

2021Cancer Chemotherapy and Pharmacology10 citationsDOI

Topics & Concepts

GenotypeCapecitabineInternal medicineMedicineGastroenterologyStage (stratigraphy)OncologyCancerMultivariate analysisProportional hazards modelLogistic regressionColorectal cancerBiologyGeneGeneticsPaleontologyCholinesterase and Neurodegenerative DiseasesCancer, Lipids, and MetabolismCancer Treatment and Pharmacology
Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine | Litcius